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Background: While studies have suggested that depression and HIV-related stigma may impede access to care, a
growing body of literature also suggests that access to HIV care itself may help to decrease internalized HIV-related
stigma and symptoms of depression in the general population of persons living with HIV. However, this has not
been investigated in postpartum women living with HIV. Furthermore, linkage to care itself may have additional
impacts on postpartum depression beyond the effects of antiretroviral therapy. We examined associations between
linkage to HIV care, postpartum depression, and internalized stigma in a population with a high risk of depression:
newly diagnosed HIV-positive pregnant women.
Methods: In this prospective observational study, data were obtained from 135 HIV-positive women from eight
antenatal clinics in the rural Nyanza Province of Kenya at their first antenatal visit (prior to testing HIV-positive for
the first time) and subsequently at 6 weeks after giving birth.
Results: At 6 weeks postpartum, women who had not linked to HIV care after testing positive at their first
antenatal visit had higher levels of depression and internalized stigma, compared to women who had linked to
care. Internalized stigma mediated the effect of linkage to care on depression. Furthermore, participants who had
both linked to HIV care and initiated antiretroviral therapy reported the lowest levels of depressive symptoms.
Conclusions: These results provide further support for current efforts to ensure that women who are newly
diagnosed with HIV during pregnancy become linked to HIV care as early as possible, with important benefits for
both physical and mental health.
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Postpartum depression is an important health problem
for many new mothers [1-3], and has negative physical
and psychological consequences for infants as well [4-9].
The prevalence of postpartum depression is estimated to
be between 10%-15% in developed countries [10], and
similar or even higher rates have been reported for low-
and middle-income countries, including countries in* Correspondence: jmturan@uab.edu
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unless otherwise stated.sub-Saharan Africa [11-18]. Many sub-Saharan countries
also have high rates of HIV infection among pregnant
and childbearing women [19]. Although there have been
efforts to improve care for women living with HIV in
sub-Saharan Africa, postpartum depression among HIV-
positive mothers remains understudied.
Pregnant women living with HIV may experience nu-
merous additional stressors, including financial hard-
ships [20,21], reduced social support [22], and concern
for the physical wellbeing of their children [23-25].
These additional stressors may increase the risk for
postpartum depression symptoms among HIV-positivetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cover their HIV-positive status during pregnancy may
be more likely to develop depressive symptoms than
those who were already aware of their HIV-positive sta-
tus before pregnancy [24].
HIV-related stigma may be another important factor
contributing to depressive symptoms for pregnant women
living with HIV. Stigma and discrimination around HIV
are common in sub-Saharan Africa, and have been associ-
ated with adverse health outcomes. Specifically, among
pregnant women, HIV-related stigma has repeatedly been
shown to be a major barrier to HIV testing and counseling
[26], utilization of labor and delivery services [27], and
participation in prevention of mother-to-child transmis-
sion (PMTCT) programs [26,28-30]. HIV-related stigma
has also been found to be associated with depression in
the general population of persons living with HIV [31-41].
However, there is very little research examining stigma
and depression simultaneously among pregnant or post-
partum women in developing countries. In one cross-
sectional study in South Africa, researchers found that
experienced stigma (having experienced actual acts of dis-
crimination) and internalized stigma (when persons living
with HIV internalize negative attitudes perceived to be
associated with HIV, resulting in feelings of low self-
worth) were strong predictors of postpartum depression
among HIV-positive women [14]. Similarly in Thailand,
researchers found that over 75% of HIV-positive postna-
tal women reported that they felt that HIV is a disease
of which their family would be ashamed, and women
who reported this familial shame were significantly
more likely to report depressive symptoms and HIV-
related worry during the postpartum period [23].
While depression and stigma may impede linkage to
HIV care, as well as adherence to antiretroviral therapy
(ART) [42], it is also possible that linkage to HIV care,
including receipt of ART, impacts both HIV-related in-
ternalized stigma and depression. One potential mechan-
ism for this effect may be that linkage to HIV care may
change perceptions related to the implications of having
HIV. It has been suggested that as perceived treatment ef-
ficacy increases for stigmatized illnesses, social stigma may
become less intense [43]. This would likely apply to per-
sons living with HIV as well: Individuals linked to HIV
care may have more positive attitudes regarding their HIV,
and experience less internalized stigma, which may lead to
higher self-esteem and feelings of being in control, which
in turn may predict lower depression symptoms. It is also
possible that linkage to care leads to lower stigma and de-
pression by improving the physical well-being of people
living with HIV [44].
Research examining the relationship between linkage
to care, stigma, and depression in the general population
of persons living with HIV has mostly focused on onecomponent of HIV care: access to ART. A 2009 system-
atic review of 21 publications (some using longitudinal
designs around the time when ART was first made avail-
able) examining the impact of ART on various outcomes
in developing countries revealed that individuals receiv-
ing ART experience less depressive symptoms than
those not receiving ART, even after controlling for phys-
ical health improvements [45-49]. The association be-
tween ART and internalized stigma is less consistent. A
few studies of stigma and ART in African countries have
suggested that ART is associated with improved self-
image and lower stigma among persons living with HIV
[44,50-53]. The rollout of ART has had significant im-
pact on health in Sub-Saharan Africa, and recent work has
suggested that the ability to work and earn a living in-
creases following ART initiation [54,55], resulting in lower
HIV-related stigma [56]. However, other studies in sub-
Saharan Africa have presented conflicting results about
the extent to which ART predicts lower HIV-related
stigma [57-60]. Furthermore, these relationships have not
been examined in pregnant or postpartum women living
with HIV.
It is important to note that linkage to comprehensive
“HIV care and treatment” extends beyond access to ART
medications, especially for pregnant women living with
HIV. However, few studies have investigated linkage to
HIV care itself in terms of impacts on mental health and
internalized HIV stigma. Many HIV care facilities in
resource-limited settings are designed to provide add-
itional services such as prevention education, family
planning counseling, infant feeding counseling, food by
prescription, couples HIV counseling and testing, and
the opportunity to participate in support groups. Under-
standing the unique roles of early linkage to care and ART
initiation for pregnant women living with HIV has par-
ticular relevance as these countries move towards Option
B+, a strategy which recommends early initiation of life-
long ART for all pregnant and postpartum women testing
HIV-positive [61]. Despite the push for option B+, cur-
rently in many countries only those pregnant women
meeting certain eligibility criteria are offered ART.
In this study, we investigated the associations among
linkage to HIV care, depression, and internalized stigma
in a population highly vulnerable to stigma and depres-
sion: newly diagnosed HIV-positive pregnant women in
rural sub-Saharan Africa (women who tested HIV-
positive for the first time at their first antenatal care visit).
We hypothesized that linkage to HIV care after testing
HIV-positive during pregnancy would be related to lower
odds of having depression (and lower depressive symp-
toms) and lower internalized stigma at six weeks postpar-
tum. Furthermore, we expected that the effects of linkage
to HIV care on depression symptoms would be partially
explained by internalized stigma. Finally, we examined
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linked to Pre-ART (linked to HIV care but not on ART
yet) versus ART care.
Methods
The setting
The data were obtained as part of a larger prospective
study—the Maternity in Migori and AIDS Stigma
(MAMAS) Study in Southern Nyanza Province, Kenya
[30]. The rate of HIV infection among MAMAS partici-
pants was 18%, which is very similar to the rate estimated
by Kenyan Antenatal Care (ANC) Sentinel Surveillance for
this region [30,62]. The study clinics were Kenyan Ministry
of Health facilities supported by Family AIDS Care &
Education Services (FACES), a PEPFAR-funded pro-
gram run by a collaboration between the Kenya Medical
Research Institute (KEMRI) and the University of
California, San Francisco (UCSF). All of the clinics had
on-site HIV care and treatment programs and provided
antiretroviral drugs for PMTCT prophylaxis to all preg-
nant women testing HIV-positive. Although eligibility
for highly active antiretroviral therapy (HAART) was re-
stricted to women with more advanced HIV disease
(CD4 count < 350 or WHO Stage III/IV), all HIV-positive
pregnant women were encouraged to enroll in the on-site
HIV care and treatment program, which provided access
to health education, adherence counseling services, patient
support groups, and other supportive services. Recruit-
ment, baseline interviews, and HIV testing took place be-
tween November 2007 and April 2009.
Participants
Participants in the larger MAMAS study included
women recruited from nine antenatal care (ANC) clinics
(N = 1777). However, one of the clinics did not provide
any follow-up data and was therefore excluded from
current analyses. All women attending a first ANC visit
at the study clinics during the study period were
approached, and if they met eligibility criteria, they were
asked if they would like to participate in the study. Partici-
pants were at least 18 years old, in their first seven months
of pregnancy, who were visiting the ANC clinic for the
first time in their pregnancy, and who did not know their
current HIV status. After providing signed informed con-
sent, participants responded to interviewer-administered
questionnaires immediately before their ANC clinic visit.
Information on participants’ acceptance of HIV testing
during the ANC visit, test results, and subsequent linkage
to care was obtained from their medical records. The
characteristics of the sample at baseline have been de-
scribed elsewhere [63].
A total of 598 women with valid locator information
were selected for participation in follow-up interviews
approximately six weeks after the birth. All women whoeither tested positive or refused testing at their first ante-
natal visit were automatically selected for follow-up, as
well as a random sample of women who tested negative
(follow-up sample: 226 HIV-positive, 227 HIV-negative,
and 145 HIV status unknown). Of the HIV-positive
women selected for follow-up, 154 (68%) participated in a
follow-up questionnaire approximately six weeks after
birth. As reported elsewhere, no important differences
were detected between those women who were inter-
viewed postpartum and those lost-to-follow-up [63]. Our
analysis focuses on HIV-positive women who participated
in both baseline and postpartum follow-up interviews, and
who had complete (non-missing) data on key variables
(n = 135). Participants were on average 5 months pregnant
at the time of the baseline interview, with limited variabil-
ity (Mean = 5.0, SD = 1.0).
Measures
All survey measures and interviews were in the partici-
pants’ preferred language (Dholuo, Kiswahili, or English).
Socio-demographics
Variables utilized in the current analyses included age,
education, marital status, number of births, and owner-
ship of a mobile phone as a proxy for wealth [27,64].
Internalized stigma
Internalized stigma was measured during the follow-up
postpartum interview using the self-stigma subscale of
HIV/AIDS Stigma Instrument–PLWA (HASI-P) [65],
which contains five items asking participants to report
how often they experience different stigma-related emo-
tions. The HASI-P was developed and validated for use
in African countries, and is available in several African
languages. In the present study, the HASI-P self-stigma
scale had good internal consistency (Cronbach’s α = .87).
Postpartum depression
At follow-up, during the postpartum quantitative inter-
view, postpartum depression was measured using the
Edinburgh Postpartum Depression Scale (EPDS) [66,67].
The EPDS is an internationally validated scale developed
specifically to assess postpartum depression and is the
most widely used measure for postpartum depression in
low- and middle-income settings [33,68-70]. Because the
EPDS does not include somatic symptoms of depression,
it is unlikely that HIV-related symptoms overlap with
EPDS measures of depression, and the EPDS has been
validated for use in HIV-positive populations in Africa
[16,18]. EPDS consists of 10 self-reported items. In the
present study, the EPDS had good internal consistency
(Cronbach’s α = .82). We used the total EPDS scale score
as a continuous variable to reflect postpartum depression
symptom severity, as well as a binary variable obtained by
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for diagnosing major depression [71].
Linkage to HIV care
We defined linkage to HIV care as enrolling in an HIV
care and treatment program and having at least one HIV
care visit. Clinic enrollment records were examined to de-
termine whether or not each participant became linked
with the HIV care and treatment program available in
their community after the baseline interview and prior to
the postpartum follow-up interview.
Other predictors in the current analyses
Partner communication about birthplace
At the postpartum interview, participants were asked
the following question: “Did you discuss where you
would deliver the baby with your husband/male partner
before the birth?” (Yes/No).
Infant Health status
At the postpartum interview, participants were asked
“Has the baby had any serious health problems since the
birth?” (Yes/No).
Family knows about HIV status
At the postpartum interview, each participant was asked
whether or not their family members know about their
HIV-positive status (Yes/No), thus including both
intentional and unintentional disclosure.
Pre/Postpartum intimate partner violence (IPV)
IPV was measured both at late pregnancy and postpar-
tum. Participants were asked whether or not they had
experienced emotional, psychological, physical, or sexual
abuse during pregnancy or after the birth. Participants
who reported IPV at either time period were categorized
as “yes”, those who chose not to answer for either period
were categorized as “unknown”, and those who reported
no IPV at both time periods were categorized as “no” [28].
ART use
During the postpartum interview, women were asked to
report if they were currently taking any antiretroviral
HIV medications (Yes/No).
Statistical analysis
Generalized estimating equations (GEE) were used to
examine the effect of linkage to HIV care on internalized
stigma and on depression symptoms as continuous vari-
ables, taking into account clustering within the study sites.
Analyses also controlled for socio-demographic character-
istics and other variables associated with postpartum de-
pression from previous research: age, marital status,
education, mobile phone ownership (as a proxy for wealth[27,64]), intimate partner violence, infant’s health status,
number of births, disclosure status, and partner communi-
cation about birth place [16,25,72]. We also examined the
effect of linkage to HIV care on depression as a dichoto-
mized diagnostic variable (EPDS ≥ 13). Next, we repeated
the analysis examining the effect of linkage to HIV care on
depressive symptoms, with internalized stigma added as a
predictor variable to the equation. To examine whether
internalized stigma mediated the effect of linkage to HIV
care on depression symptoms, we conducted exploratory
mediation analyses using the ml_mediation program,
which utilizes the procedures that Krull and MacKinnon
[73] proposed for calculating and testing mediation effects
(i.e., indirect effects) in clustered data. Lastly, we con-
ducted GEE analyses to compare postpartum depression
symptoms for the following three groups: a) not linked to
HIV care, b) linked to HIV care but not on ART, c) linked
to HIV care and on ART.
Ethical review
This study received ethical approval from the Kenya
Medical Research Institute (KEMRI) Ethical Review
Committee, the University of California, San Francisco
Committee on Human Research, and the University of
Alabama at Birmingham Institutional Review Board. All
women provided written informed consent for participa-
tion in the questionnaires and abstraction of data from
their medical records.
Results
Descriptive statistics for the main study variables are
presented in Table 1. Of the 135 women included in the
analyses, 34 (25.2%) were depressed according the EPDS
criteria of a score of ≥ 13. Fifty-six participants had not
linked to HIV care, whereas 79 participants had linked
to HIV care (58.5%). As expected, depression scores
were significantly correlated with internalized stigma
scores (r = .56, p < .01).
Linking to HIV care and postpartum depression
Non-linkage to HIV care was a significant predictor of
postpartum depression symptoms: Women who had not
linked to HIV care had higher levels of depression com-
pared to women who had linked to HIV care (See Table 2
for statistical results). Other significant predictors of post-
partum depressive symptoms included intimate partner
violence (women experiencing partner violence and
women who had missing data on violence had higher
levels of depression), disclosure (women whose HIV status
is known to someone in their family had higher levels of
depression), number of births (women with fewer births
had higher levels of depression), infant’s health problems
(women whose babies had health problems had higher
levels of depression), and partner communication about
Table 1 Characteristics of the sample (N = 135 HIV
positive women)
Variable Mean (SD) or
percentagea
Socio-demographic characteristics
Mean age 24.26 (4.87)
Marital status (%)
Not currently married 12.6
Currently married 87.4
Educational level (%)
Primary or less 88.1
More than primary 11.9
Household goods (%)
Owns a mobile phone 41.5
Does not own a mobile phone 58.5
HIV-related characteristics
Mean HASI-P Internalized HIV-related Stigma score 0.64 (0.81)
Linked to HIV care (%)
Yes 58.5
No 41.5




Partner communication about birthplace (%)
No discussion of delivery with partner before the birth 32.6
Discussion of delivery with partner 67.4




Mean number of births 2.10 (1.61)
Infant health status (%)
No serious health problems after birth 80.7
Serious health problems after birth 19.3
Mean postpartum depression score (EPDS) 7.94 (5.59)
EPDS category (%)
EPDS ≥13 possible depression 25.2
EPDS <13 74.8
Note. aMean (SD) are presented for continuous variables.
Table 2 Multivariable generalized estimating equation





Age .08 (0.14) .562
Marital status (ref: not currently married)
Currently married −0.01 (0.94) .996
Educational level (ref: more than primary)
Primary or less −1.82 (1.76) .301
Mobile phone ownership (ref: yes)
No -.59 (1.05) .576
Pre/postpartum intimate partner
violence (ref: none)
Yes 4.67 (0.84) .000
Unknown 2.26 (0.77) .003
Infant health problems after birth (ref: no)
Yes 3.47 (0.72) .000
Number of births −0.66 (0.28) .019
Family knows about HIV status (ref: no)
Yes 1.35 (0.66) .040
Spousal communication about
birthplace (ref: no)
Yes −2.31 (0.61) .000
Linked to care (ref: no)
Yes −1.85 (0.91) .043
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of the upcoming birth with their partner had higher levels
of depression).
Next, we repeated the GEE analyses using the dichoto-
mized depression variable (EPDS ≥ 13, using binary logis-
tic models). Linkage to care was significantly associated
with lower odds of depression (odds ratio (OR) = 0.33,95% CI = 0.16 - 0.69). Thus, this analysis also indicated
that women who had not linked to HIV care were more
likely to have symptoms consistent with a diagnosis of
postpartum depression compared to women who had
linked to HIV care.Linkage to care and internalized stigma
Linkage to HIV care was also negatively associated with
internalized stigma. Women who had not enrolled in care
had higher levels of stigma at the time of the postpartum
interview, compared to women who had enrolled, control-
ling for covariates (see Table 3 for statistical details). Other
significant predictors of internalized stigma were intimate
partner violence (women experiencing partner violence
and women who had missing data on violence had higher
levels of stigma), disclosure (women whose HIV status is
known to someone in their family had higher levels of
stigma), number of births (women with fewer births had
higher levels of stigma), and partner communication about
the birth place (women who did not discuss the location
of the upcoming birth with their partner had higher levels
of stigma).
Table 3 Multivariable generalized estimating equation





Age 0.02 (0.02) .282
Marital status (ref: not currently married)
Currently married 0.05 (0.21) .818
Educational level (ref: more than primary)
Primary or less −0.43 (0.33) .188
Mobile phone ownership (ref: yes)
No −0.12 (0.07) .086
Pre/postpartum intimate partner
violence (ref: none)
Yes 0.35 (0.14) .011
Unknown 0.26 (0.16) .022
Infant health problems after birth (ref: no)
Yes 0.15 (0.13) .237
Number of births −0.10 (0.05) .037
Family knows about HIV status (ref: no)
Yes 0.37 (0.19) .046
Spousal communication about
birthplace (ref: no)
Yes −0.25 (0.12) .039
Linked to care (ref: no)
Yes −0.34 (0.15) .024
Table 4 Multivariable generalized estimating equation
analysis predicting postpartum depression severity with




Age 0.03 (0.10) .764
Marital status (ref: not currently married)
Currently married −0.15 (0.48) .765
Educational level (ref: more than primary)
Primary or less −0.57 (0.85) .502
Mobile phone ownership (ref: yes)
No −0.24 (0.92) .792
Pre/postpartum intimate partner
violence (ref: none)
Yes 3.67 (0.87) .000
Unknown 1.50 (0.51) .004
Infant health problems after birth (ref: no)
Yes 3.03 (0.83) .000
Number of births −0.38 (0.23) .098
Family knows about HIV status (ref: no)
Yes 0.28 (0.88) .746
Discussion of delivery with partner (ref: yes)
No 1.60 (0.43) .000
Linked to care (ref: no)
Yes −0.86 (0.713) .226
HASI-P internalized HIV-related stigma 2.88 (.570) .000
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Next, we repeated the GEE analysis with symptoms of
postpartum depression as the outcome and with inter-
nalized stigma added to the equation as a predictor (see
Table 4 for statistical details). In this model, internalized
stigma was a significant predictor of depression: Women
with higher internalized stigma had higher levels of depres-
sion. With stigma in the model, linkage to HIV care was
no longer a significant predictor of postpartum depression
symptoms. Mediation analysis for clustered data revealed a
significant indirect effect of linkage to HIV care on depres-
sion, mediated by stigma (coefficient = −.61, p < .05, 95%
bias-corrected confidence interval = −1.22 to -.11).
Thus, this analysis provided evidence that stigma medi-
ated the effect of linkage to HIV care on lower depres-
sion symptoms.
Next, we repeated the GEE analyses using the dichoto-
mized depression variable (EPDS ≥ 13, using binary logis-
tic models) with internalized stigma added as a predictor.
In this model, stigma was a significant predictor of depres-
sion status (OR = 3.67, 95% CI = 1.87 - 7.22): Women
with higher internalized stigma were more likely to be de-
pressed. With stigma in the model, linkage to care was stilla significant predictor of depression status; however,
the effect of linkage was reduced (OR = 0.45, 95% CI =
0.22 - 0.90).The role of ART
Of the 79 participants included in the GEE multivariate
analyses who had linked to HIV care, 33 (42%) were on
ART. We compared postpartum depression symptoms
for the following three groups: a) not linked to HIV care,
b) linked to HIV care but not on ART, c) linked to HIV
care and on ART. GEE analyses with this three-category
variable (and the control variables) suggested that both
of the first two groups (not linked to HIV care and
linked but not on ART) had significantly more postpar-
tum depression symptoms than the third group (linked
and on ART; B = 3.20 and B = 2.26, respectively, both p
values <= 0.001). There were no significant differences
between the first two groups (not linked to HIV care
versus linked but not on ART; B = 0.94, p = 0.37). The
estimated marginal means for postpartum depression
symptoms for the three groups were: 11.95, 11.01, and
8.75, respectively for a) not linked to HIV care, b) linked
but not on ART, and c) linked and on ART.
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sion variable as the dependent variable (depressed de-
fined as EPDS ≥ 13) led to similar results. Both of the
first two groups (not linked to HIV care and linked but
not on ART) were significantly more likely to be de-
pressed than the third group (linked and on ART; OR =
7.91, 95% CI = 2.79 – 22.44 and OR = 4.33, 95% CI =
1.80 – 10.40, respectively, both p values <= 0.001). There
were no significant differences between the first two
groups (not linked to HIV care versus linked but not on
ART; OR = .55, 95% CI = .25 – 1.18, p = 0.12).
Discussion
We examined postpartum depression symptoms and in-
ternalized stigma levels six weeks after birth for women
who tested HIV-positive for the first time during their
first ANC visit. We found that HIV-positive pregnant
women who had linked with HIV care had significantly
lower levels of depression symptoms (as well as lower
postpartum depression rates using the recommended
cutoff score for major depression) at around six weeks
after the birth, as compared to HIV-positive women who
did not link with HIV care. We also identified an im-
portant potential mediator for this effect: It appears that
linkage to HIV care is associated with lower internalized
HIV-related stigma, which in turn predicts lower post-
partum depression symptom severity. ART seemed to be
an important component of this effect on depression
symptoms, with depression levels being lowest in women
who were both linked to HIV care and on ART. This last
finding (although based on a small sample size) lends
further support to current efforts to roll out Option B+,
the WHO-recommended strategy of initiating all HIV-
positive pregnant women on lifelong ART, regardless of
initial stage of HIV disease [74].
The findings of the current study are particularly rele-
vant as the global community struggles to achieve opti-
mal maternal and child health outcomes in sub-Saharan
Africa, including HIV-free infant survival. HIV-infected
pregnant women in sub-Saharan Africa are a highly vul-
nerable group (especially those who become aware of
their HIV infection during pregnancy), and it is very im-
portant to protect their mental as well as physical health
[75]. This study fills a gap in the current literature by
examining the associations between linkage to HIV care
and postpartum depression among pregnant women in a
rural setting in sub-Saharan Africa.
This study also adds to the current body of literature by
examining the effects of linkage to care itself (Pre-ART
care, which includes a package of services that may benefit
mental health) versus the effects of linkage to care and be-
ing on ART. There has been little previous research
attempting to tease apart the separate effects of ART
medication and other components of HIV care on theseoutcomes. Linkage to HIV care and the opportunity to
take advantage of other supportive services may result in
lower stigma and/or depression, especially for pregnant
women, who are particularly vulnerable to depression
[14,22,23]. Although the current analyses are based on a
relatively small sample size, the findings point to the possi-
bility that ART is an important component of the effect of
linkage to HIV care on postpartum depression.
Internalized HIV-related stigma and depression both in-
clude aspects such as self-blame and self-devaluation, and
hence may be similar constructs. Although in this study
we found these measures to be correlated, they appeared
to be distinct aspects of the experiences of many newly di-
agnosed pregnant and postpartum women living with HIV
in our sample. We found that internalized HIV-related
stigma was a mediating factor in the association between
linkage to HIV care and depression in this population.
The other variables that were found to be significantly
related to postpartum depression in this setting are, for
the most part, in agreement with existing literature. In-
timate partner violence has consistently been shown to
be related to adverse mental health outcomes in women
[76], and has been shown to be an important predictor
of perinatal depression [72]. Having an infant with
health problems has also been found to be an important
predictor in some settings [25,77,78]. Number of births
was found to be an important predictor of postpartum
depression in HIV-infected women in Zimbabwe [17],
although in the opposite direction found in the current
study. Our analyses also suggest important roles of
family’s knowledge about the woman’s HIV-positive sta-
tus and communication with the male partner in under-
standing postpartum depression for women living with
HIV in this rural Kenyan setting. These same factors
(with the exception of infant health status) also pre-
dicted HIV-related internalized stigma.
Our results should be evaluated in the context of the
limitations of this study. Only 70% of the original sample
could be located and participated in the follow-up assess-
ment after the birth. However, as reported elsewhere, no
important differences were detected between those women
who could be located and interviewed postpartum and
those lost-to-follow-up [63]. Although we hypothesized
that lower internalized HIV-related stigma leads to lower
postpartum depression in our mediation analyses, these
variables were measured at the same time point (i.e., dur-
ing the postpartum interview). Because pregnant women
were interviewed at baseline before their initial ANC visit
and before they knew their HIV status, we were not able to
collect baseline data on internalized HIV-related stigma. In
addition, a large proportion of women in the sample did
not link to HIV care, meaning that we were not able to ob-
tain data on their stage of HIV disease, and we only had
self-report data on women’s current ART use.
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finitive evidence for a causal role of linkage to HIV care
in affecting depression or stigma. However, we have ad-
justed our analyses for socio-demographics and several
key predictors from the literature. Ancillary analyses on
a limited subsample of women included in the current
analyses who completed an additional questionnaire dur-
ing late pregnancy (n = 67) suggested that depression
symptom severity was not very stable from late preg-
nancy to six weeks after the birth (Pearson r = 0.25).
Thus, it is not likely that late pregnancy depression was
a confounding variable in the association between link-
age to care and postpartum depression. Repeating our
main analysis on the limited subsample of women for
whom we had late pregnancy data yielded a similar effect
size for the association between linkage to care and post-
partum depression controlling for depression at late preg-
nancy (B = −1.51, p = .07, n = 64 for the effect of linkage to
care) compared to our main analyses where depression at
late pregnancy was not controlled (B = −1.85, p = .04, N =
135; see Table 2).
Important strengths of the study include the prospect-
ive study design targeting a particularly vulnerable popu-
lation: Participants were interviewed immediately before
their first ANC visit and again around six weeks after
the birth and only those participants who tested positive
for HIV for the first time were included. Other strengths
include the utilization of medical record data, rather
than self-report, for our key predictor variable of linkage
to care, and detailed analyses controlling for important
variables that may be related to our outcome variables.
Conclusions
Linkage to HIV care, especially when combined with
ART, may predict lower postpartum depression symp-
toms (as well as lower postpartum depression rates) and
lower internalized stigma among newly diagnosed post-
partum women living with HIV. Our analyses suggest
that linkage to care may potentially help prevent post-
partum depression symptoms through helping women
to cope with stigma and reducing internalized stigma.
Thus, along with other health benefits, interventions fo-
cusing on linkage to care and initiation of ART may help
to protect the mental health of pregnant and childbear-
ing women in sub-Saharan Africa, with important bene-
fits for maternal and child health.
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